Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end stage renal disease

Design of Phase III trials in diabetic nephropathy currently requires patients at high risk of progression defined as within three years of a hard end-point (end stage renal disease, 40% loss of estimated glomerular filtration rate, or death). To improve design of these trials, we used natural histo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int
Main Authors: Yamanouchi, Masayuki, Skupien, Jan, Niewczas, Monika A., Smiles, Adam, Doria, Alessandro, Stanton, Robert C., Galecki, Andrzej, Duffin, Kevin L., Pullen, Nick, Breyer, Matthew D., Bonventre, Joseph V., Warram, James H., Krolewski, Andrzej S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5796779/
https://ncbi.nlm.nih.gov/pubmed/28396115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2017.02.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados